IDYA (STOCKS)
IDEAYA Biosciences, Inc. Common Stock
$36.680000
-0.280000 (-0.76%)
Prev close: $36.960000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Yujiro S. Hata
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,696.71M
- Employees
- 131
- P/E (TTM)
- -18.88
- P/B (TTM)
- 2.97
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $234.13M |
| Benefits Costs and Expenses | $409.15M |
| Costs And Expenses | $405.47M |
| Nonoperating Income/Loss | $41.93M |
| Operating Expenses | $451.08M |
| Depreciation and Amortization | $2.80M |
| Research and Development | $374.01M |
| Other Operating Expenses | $74.27M |
| Operating Income/Loss | -$216.95M |
| Income/Loss From Continuing Operations After Tax | -$175.02M |
| Income/Loss From Continuing Operations Before Tax | -$175.02M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$175.02M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$175.02M |
| Net Income/Loss Available To Common Stockholders, Basic | -$175.02M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.92 |
| Diluted Earnings Per Share | -$1.94 |
| Basic Average Shares | 178,949,514 |
| Diluted Average Shares | 180,113,611 |
| Assets | $1.31B |
| Current Assets | $864.03M |
| Noncurrent Assets | $445.67M |
| Fixed Assets | $8.28M |
| Other Non-current Assets | $437.39M |
| Liabilities | $110.79M |
| Current Liabilities | $82.68M |
| Accounts Payable | $30.51M |
| Wages | $9.04M |
| Other Current Liabilities | $43.13M |
| Noncurrent Liabilities | $28.12M |
| Equity | $1.20B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.20B |
| Liabilities And Equity | $1.31B |
| Net Cash Flow From Operating Activities | -$111.66M |
| Net Cash Flow From Operating Activities, Continuing | -$111.66M |
| Net Cash Flow From Investing Activities | -$92.74M |
| Net Cash Flow From Investing Activities, Continuing | -$92.74M |
| Net Cash Flow From Financing Activities | $362.82M |
| Net Cash Flow From Financing Activities, Continuing | $362.82M |
| Net Cash Flow | $158.42M |
| Net Cash Flow, Continuing | $158.42M |
| Comprehensive Income/Loss | -$178.21M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$178.21M |
| Other Comprehensive Income/Loss | $116.05M |
| Other Comprehensive Income/Loss Attributable To Parent | -$3.19M |